Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $756.56 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $499.60 | 23 | $0 (2024) |
| Braintree Laboratories, Inc. | $56.32 | 3 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $48.21 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $39.72 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.07 | 2 | $0 (2021) |
| RedHill Biopharma Inc. | $38.03 | 2 | $0 (2021) |
| PFIZER INC. | $19.75 | 1 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $15.86 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.74 | 1 | ABBVIE INC. ($29.74) |
| 2023 | $156.69 | 7 | AbbVie Inc. ($135.07) |
| 2022 | $114.95 | 5 | ABBVIE INC. ($114.95) |
| 2021 | $189.20 | 9 | AbbVie Inc. ($89.28) |
| 2020 | $36.90 | 2 | AbbVie Inc. ($20.44) |
| 2019 | $229.08 | 13 | AbbVie, Inc. ($110.12) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/10/2023 | AbbVie Inc. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Gastroenterology | ||||||
| 12/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/06/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2021 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/02/2021 | RedHill Biopharma Inc. | Movantik (Drug), Talicia | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Opioid Antagonist | ||||||
| 06/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/27/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: IMMUNOLOGY | ||||||
| 05/13/2021 | Braintree Laboratories, Inc. | MOTOFEN (Drug), SUTAB | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: GASTROENTEROLOGY - DIARRHEA | ||||||
| 04/23/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2020 | RedHill Biopharma Inc. | Aemcolo (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Antibiotic | ||||||
| 02/13/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 290 | 291 | $529,688 | $33,663 |
| 2022 | 4 | 748 | 750 | $730,050 | $86,073 |
| 2021 | 4 | 563 | 575 | $1.4M | $77,505 |
| 2020 | 4 | 394 | 401 | $1.4M | $63,894 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 71 | 71 | $75,328 | $7,600 | 10.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Office | 2023 | 44 | 44 | $106,959 | $5,383 | 5.0% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Office | 2023 | 30 | 30 | $126,239 | $3,979 | 3.2% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 37 | 37 | $36,150 | $3,954 | 10.9% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Office | 2023 | 23 | 23 | $63,210 | $3,696 | 5.8% |
| 00142 | Anesthesia for lens surgery | Facility | 2023 | 32 | 33 | $51,917 | $3,359 | 6.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 31 | 31 | $40,741 | $3,339 | 8.2% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 22 | 22 | $29,145 | $2,353 | 8.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 213 | 215 | $203,400 | $24,482 | 12.0% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 179 | 179 | $200,400 | $23,725 | 11.8% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 202 | 202 | $187,650 | $21,436 | 11.4% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 154 | 154 | $138,600 | $16,430 | 11.9% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2021 | 192 | 198 | $638,000 | $27,968 | 4.4% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 112 | 117 | $360,000 | $17,172 | 4.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 54 | 54 | $54,250 | $5,832 | 10.8% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 52 | 52 | $61,650 | $5,818 | 9.4% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 41 | 41 | $46,200 | $5,664 | 12.3% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 48 | 48 | $54,900 | $5,293 | 9.6% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2021 | 37 | 38 | $122,400 | $5,081 | 4.2% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2021 | 27 | 27 | $96,800 | $4,677 | 4.8% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Office | 2020 | 197 | 199 | $717,300 | $33,313 | 4.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 102 | 106 | $335,800 | $15,979 | 4.8% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Office | 2020 | 43 | 44 | $156,950 | $6,591 | 4.2% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Office | 2020 | 29 | 29 | $112,300 | $5,296 | 4.7% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 12 | 12 | $18,050 | $1,463 | 8.1% |
About Dr. Swapnil Shetye, M.D
Dr. Swapnil Shetye, M.D is a Anesthesiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588606917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Swapnil Shetye, M.D has received a total of $756.56 in payments from pharmaceutical and medical device companies, with $29.74 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($756.56).
As a Medicare-enrolled provider, Shetye has provided services to 1,995 Medicare beneficiaries, totaling 2,017 services with total Medicare billing of $261,134. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Brooklyn, NY
- Active Since 06/11/2006
- Last Updated 07/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1588606917
Products in Payments
- SKYRIZI (Biological) $158.85
- RINVOQ (Biological) $120.91
- Creon (Drug) $74.75
- HUMIRA (Biological) $65.51
- MOTOFEN (Drug) $56.32
- DIFICID (Drug) $48.21
- XIFAXAN (Drug) $39.72
- Humira (Biological) $35.37
- VIBERZI (Drug) $23.77
- Movantik (Drug) $21.57
- CREON (Drug) $20.44
- ENTYVIO (Biological) $20.03
- INFLECTRA (Biological) $19.75
- MOTEGRITY (Drug) $19.04
- Aemcolo (Drug) $16.46
- CLENPIQ (Drug) $15.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Brooklyn
Dr. Mark Kronenfeld, M.d, M.D
Anesthesiology — Payments: $2.5M
Mehrdad Hedayatnia, Md, MD
Anesthesiology — Payments: $27,710
Jason Kreiner, M.d, M.D
Anesthesiology — Payments: $19,382
Roman Shulkin, M.d, M.D
Anesthesiology — Payments: $15,731
Dr. Edwin Perez, M.d, M.D
Anesthesiology — Payments: $11,545
Shaesta Humayun, Md, MD
Anesthesiology — Payments: $7,219